Search results
Found 31107 matches for
Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?
Srinivasa Rao Rao
MBBS, MS (res), DPhil, AFHEA Srinivasa Rao Rao - Senior Researcher in Cancer Genomics
Akira Wiberg
BA BM BCh DPhil FRCS(Plast) Akira Wiberg - Senior Clinical Research Fellow
Charlotte Bell
Charlotte Bell - Program Director – Industry Liaison in Experimental Medicine
Maria Navarro Perez
Maria Navarro Perez - Postdoctoral Research Assistant
Pak Hnag (Patrick) Wan
Pak Hnag (Patrick) Wan - Data Collection and Processing Assistant
Ioana Marian
MSc Ioana Marian - OCTRU Senior Medical Statistician